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i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 6 1 6 – 6 2 6620websites of different cardiac societies and INTERNET. In the
Internet, we clicked the subjects' name with Indian
perspective and tried to ﬁnd out relevant information for
our purpose. (iii) Last, we personally contacted several
resourceful individuals /senior cardiologists and obtained
information from them, which was subsequently cross-
veriﬁed, either from Internet or journals (as far as possible).
4 THEN we classiﬁed the data into different categories: (i) High
evidence - articles or abstracts published in peer-reviewed
journals or in ofﬁcial website of professional bodies (ii)
Intermediate evidence - articles published in text books or
update books (iii) Low evidence - information gathered from
individuals. Once we were satisﬁed that the subject indeed
had evidence, we mentioned it in our article. We also
mentioned the names of the place or Institutes wherever
possible.
5 The prominence of surgery and invasive cardiology stems
from the fact that there has been the trend in last three to four
decades both nationally and internationally to have more
publications (and therefore more hard evidence). However,
we do feel that other areas should also be given more
prominence. We believe there is a plan to bring out a




Evidence based medicine6 We believe, this article is just the beginning (Mother of series
of articles) and aims at revealing the truth of our (India's)
strength in the ﬁeld of Cardiology which really started in pre-
Vedic era. Understanding and interpretation of history is not
absolute. Study of history enriches by writing same history
from different angles and perspectives. There is no differ-
ence in opinions regarding this.
7 We re-iterate that we had a humble beginning based on
evidence and the subsequent suggestions by our community
members and esteemed seniors will be put forward to the
Editor and these ideas, reﬂections, suggestions are certainly
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Develop Indian guidelines and revolutionize the heath
care systemDear Sir,
We read the article ‘‘Are western guidelines good enough for
Indians? My name is Borat’’ by Sundeep Mishra and Vivek
Chaturvedi in Indian Heart Journal1 and felt a drastic
transformation in IHJ discussing more relevant and sensitive
issues like never before. I fully support the author, who has
very intelligently and appropriately discussed important
factors for making, developing, and need for Indian guide-
lines. After going through the article, the important question
coming to my mind is that 'Do clinical practice guidelines
(CPGs) whether Indian or others inﬂuence practice in Indian
Scenario'. ‘‘Incredible India’’ is a land of contrasts. This is
nowhere more evident than in health care today. On the one
hand, India boasts of brilliant doctors practicing state of the
art medicine using the latest technology and guidelines, and
on the other hand, majority of India's health care services
are unregulated, where majority of population do not haveaccess to qualiﬁed medical care leaving them at the mercy of
quacks putting a big question mark on implementation of
CPGs.
In India, there is nonuniformity of the standards of the care
of patients from state to state, city to city and hospital to
hospital. Only the premier institutes in the country both
private or government have ways and means to adopt state-of-
the-art medical care, otherwise the state-of-the-art medical
care is virtually absent in majority of government hospitals,
small private setups and rural hospitals.
The most striking feature of the management of patients
in India is its heterogeneity: from tertiary and teaching
hospitals providing best possible evidence-based health
care, to small private or government hospitals generally
overburdened compromising on evidence based health care.
The challenge for Indian healthcare lies in setting right this
imbalance.
Registries and surveys collect data rapidly and efﬁciently,
allowing an analysis of current trends in disease incidence,
treatment and outcomes, but is still in infancy in India. Web-
based secure communication systems have revolutionized
data collection systems in medical research providing oppor-
tunities for studies with exceptionally large sample sizes and
have the potential to provide timely information about various
disease factors. Despite India's internationally renowned
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 6 1 6 – 6 2 6 621competence in information technology, there are no web-
based disease registries for CVDs.2
I feel, the author, along with stressing on the need for
Indian guidelines, should have focused also on streamlining
the total health care system, because if health care system is
not streamlined with more focus on public healthy care,
guidelines whether Indian or otherwise will be affecting only
the miniscule population.
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Comment on ‘‘Prospective study to evaluate safety and
efﬁcacy of Zotarolimus Eluting Stent (PSEZES) in
patients with long coronary artery lesions’’Sir,
I read with interest the research article titled ‘‘Prospective
study to evaluate safety and efﬁcacy of Zotarolimus Eluting
Stent (PSEZES) in patients with long coronary artery lesions’’
by Bahuleyan et al.1 Heart of the matter is how safe is long
stents in the treatment of coronary artery disease (CAD), either
in acute or chronic condition. Numerous trials have demon-
strated that PCI may reduce symptoms ischemia, save lives,
and prevent myocardial infarction (MI) in either condition. The
longer the stent length, it is more difﬁcult to ensure its long-
duration patency. The thumb rule is that with each 1 mm
increase in stent length, the restenosis rate is increased by 1%.There are signiﬁcant gradients across the outcomes, as lesion
features change from type A to C. Even type C is not singular
but a family of difﬁcult lesions, and each one poses a unique
challenge during procedure and follow-up. The residual
platelet activity needs individual tailoring in the type of
antiplatelet and its dose2 with other medications rightly in
place in the prescription in a patient with good compliance.
The procedure itself, and the immediate and the late outcome
of every PCI done, are highly affected by the proﬁle of the
patient, lesion category, the chosen stent, skill of the operator,
and not the least by appropriately chosen antiplatelet. The
immediate and late adverse events, such as stent thrombosis
(ST) and target lesion revascularization (TLR), are continuous
hazards, and those should be the primary targets for
developing improved long-term patency of coronary
stents.3–5 Sometimes, target vessels react in form of dissection
in the ostium and in the edge in the context of intervention of
complex lesions or using unusual hardware. When compared
to LAD and RCA, PCI of complex lesion in LCX is associated
with lower procedural success, higher complication rates, and
less long-term patency.6 Therefore, in search of incremental
safety of stent in coronary disease, the research timeline
touches POBA, BMS, DES, biodegradable polymer, and BVS.
